Notably, ACSL4 has been previously studied by Zhang et al., who demonstrated its role in aggravating LPS-induced intestinal epithelial damage through activating both ferroptosis and pro-inflammatory responses, thereby driving inflammatory bowel disease progression (49). The gene discussed is ACSL4; the disease is inflammatory bowel disease.